S

$SNOW

48 articles found
4 positive
35 negative
9 neutral
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Snowflake Faces Class Action Lawsuit Over $SNOW Stock Plunge Following Revenue Guidance Miss

Pomerantz Law Firm filed securities fraud lawsuit against Snowflake after February 2024 revenue warning triggered 18% stock decline. Investors can join until April 2026.
NAVNSNOWAMCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

AMC Class Action Over Excluded Dividend Reveals Securities Law Risks for Preferred Shareholders

Pomerantz Law Firm alleges AMC excluded APE preferred shareholders from special dividend through contractual loophole. Lead Plaintiff deadline: April 20, 2026.
NAVNSNOWAMCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Navan Faces Class Action Over IPO Disclosure Gaps as Pomerantz Targets Securities Violations

Pomerantz Law Firm filed class action lawsuit against Navan, alleging the company concealed 39% surge in sales/marketing expenses around October 2025 IPO.
NAVNSNOWAMCsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

Mereo BioPharma Stock Collapsed 87.7% After Trial Failure; Class Action Deadline Looms

Pomerantz Law Firm filed class action against $MREO after Phase 3 trial failures. Stock plummeted 87.7%. Investor deadline: April 6, 2026.
NAVNSNOWMREOsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Pomerantz Llp

PayPal Faces Class Action Lawsuit After Earnings Miss, CEO Exit, and Guidance Withdrawal

PayPal faces class action lawsuit following Q4 2025 earnings miss, CEO departure, and withdrawn 2027 guidance amid operational challenges.
SNOWPYPLNUVBsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

Boston Scientific Faces Securities Lawsuit Over Electrophysiology Market Misrepresentation

Boston Scientific faces class action lawsuit alleging misleading statements about electrophysiology market position, with stock down 17% after missing earnings guidance.
SNOWBSXDRVNsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Snowflake Hit With Class Action Over Undisclosed Product Changes, CEO Claims

Snowflake faces class action alleging company concealed material information about product changes harming revenue while making misleading positive statements through early 2024.
SNOWsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Levi & Korsinsky, Llp

Snowflake Faces Major Securities Lawsuit Over Misleading Revenue Guidance

Securities class action filed against $SNOW alleging officers made materially misleading statements about revenue growth and 2029 targets, triggering 18% stock decline.
SNOWsecurities fraudstock decline
The Motley FoolThe Motley Fool··Will Ebiefung

$PLTR Faces Steep Valuation Cliff: Analysts Warn of 25-50% Further Decline

$PLTR stock down 24% from November peak; analysts warn of additional 25-50% decline as P/E ratio of 230 far exceeds market norms despite strong 70% revenue growth.
NVDAMSFTSNOWPLTRenterprise softwarerevenue growth
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman, Llc

Class Action Lawsuits Filed Against $SDM and $SNOW Over Securities Fraud Allegations

Law firm Bronstein, Gewirtz & Grossman files securities fraud class actions against $SDM and $SNOW with lead plaintiff deadlines in March and April 2026.
SDMSNOWsecurities fraudclass action
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Snowflake Faces Securities Fraud Class Action Over Undisclosed Business Headwinds

Class action lawsuit filed against $SNOW alleges securities fraud over material nondisclosure of product changes and CEO transition, spanning June 2023-February 2024.
SNOWsecurities fraudclass action lawsuit
The Motley FoolThe Motley Fool··Anthony Di Pizio

Snowflake Stock Plunges 20% Despite Bull Case: Wall Street's Contrarian View

Snowflake stock fell 20% in 2026 despite bullish analyst ratings. Critics argue valuation remains elevated despite slowing growth and rising losses.
METAMSFTAMZNGOOGGOOGL+1stock declinecloud computing
The Motley FoolThe Motley Fool··Geoffrey Seiler

Snowflake's Strong Fundamentals Meet Valuation Reality Check

Snowflake delivered 30% revenue growth and solid customer metrics, but a 20% year-to-date decline and 10x forward P/S multiple present mixed signals for investors.
SNOWSnowflakerevenue growth
Investing.comInvesting.com··Tafara Tsoka

Seven High-Flying US Stocks Face Valuation Risk as Cash Flow Weakness Looms

Analysis flags Rivian, Snowflake, Lucid, Palantir, DoorDash, Upstart, and Carvana as overvalued despite weak free cash flow generation, signaling potential volatility ahead.
SNOWPLTRUPSTCVNALCID+2cash burnfree cash flow
The Motley FoolThe Motley Fool··Howard Smith

Palantir Surges on Defense AI Boom: Q4 Growth, $1B DHS Deal Drive Rally

Palantir surges 5.87% on strong Q4 with 56% revenue growth and $1B DHS contract, buoyed by defense AI demand amid geopolitical tensions.
SNOWPLTRQ4 resultsgovernment contracts
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Snowflake Faces Major Securities Lawsuit Over Undisclosed Product Impact

Rosen Law Firm sues Snowflake for allegedly hiding how new products would harm consumption and revenue. Lead plaintiff deadline: April 27, 2026.
SNOWsecurities fraudclass action lawsuit
BenzingaBenzinga··Lekha Gupta

Tech Giants Navigate Trade Turbulence as AI Race Intensifies

US-Taiwan tensions escalate amid tariff shifts. Amazon invests $12B domestically while Apple relocates Mac production to Texas. AI developments dominate sector headlines.
NVDAAMDMETAMSFTAMZN+22AI investmentautonomous vehicles
Investing.comInvesting.com··Thomas Hughes

Snowflake Shows Recovery Signals Amid Valuation Reset and AI Momentum

Snowflake shows recovery signals with 30% revenue growth, steady 125% net retention, and renewed institutional buying. AI partnerships and analyst optimism suggest potential 50% upside.
NVDASNOWSnowflakeinstitutional buying
GlobeNewswire Inc.GlobeNewswire Inc.··Bronstein, Gewirtz & Grossman Llc

Securities Fraud Lawsuit Filed Against Snowflake Over Undisclosed Business Impact

Class action lawsuit filed against Snowflake for allegedly making misleading statements about business impact while concealing product efficiency changes and pricing adjustments between June 2023 and February 2024.
SNOWsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Rosen Law Firm

Mereo BioPharma Faces Securities Litigation Over Clinical Trial Disclosures

Mereo BioPharma faces securities lawsuit alleging misrepresentations about Phase 3 trial results for setrusumab, causing investor losses.
SNOWMREOsecurities fraudsecurities class action